Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-037024

Alexza Pharmaceuticals Inc. · ALXA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Edwin S Kamemoto
Officer — EVP, R&D and Quality
Period of report
Apr 28, 2015
Accepted (ET)
Apr 29, 2015 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001344413

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———6,250D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2$1.95Apr 28, 2015A35,000AApr 28, 2016Apr 27, 2025Common Stock35,00035,000D

Explanation of responses